Production of oligodendrocytes from placenta-derived stem cells
US8071376B2 · kind B2 · utility
36Cited by
16References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 13, 2006 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Aug 18, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and compositions for the production of glial cells and oligodendrocytes from placenta stem cells. The invention further provides for the use of these glia and oligodendrocytes in the treatment of, and intervention in, for example, trauma, ischemia and degenerative disorders of the central nervous system (CNS), particularly in the treatment of demyelinating diseases such as multiple sclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.